Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Cancer Communications |
| Online Access: | https://doi.org/10.1002/cac2.70035 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849233300873281536 |
|---|---|
| author | Edmund Chiong Ziteng Wang Eleanor Jing Yi Cheong Yi Chen Yao Sin Mun Tham Revathi Periaswami Poh Choo Toh Ziting Wang Qing Hui Wu Woon Chau Tsang Arshvin Kesavan Alvin Seng Cheong Wong Patrick Thomas Wong Felicia Lim Shuaibing Liu Eric Chun Yong Chan |
| author_facet | Edmund Chiong Ziteng Wang Eleanor Jing Yi Cheong Yi Chen Yao Sin Mun Tham Revathi Periaswami Poh Choo Toh Ziting Wang Qing Hui Wu Woon Chau Tsang Arshvin Kesavan Alvin Seng Cheong Wong Patrick Thomas Wong Felicia Lim Shuaibing Liu Eric Chun Yong Chan |
| author_sort | Edmund Chiong |
| collection | DOAJ |
| format | Article |
| id | doaj-art-0b5aa64bff954e04a27ffa8cf00b5498 |
| institution | Kabale University |
| issn | 2523-3548 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Communications |
| spelling | doaj-art-0b5aa64bff954e04a27ffa8cf00b54982025-08-20T08:40:33ZengWileyCancer Communications2523-35482025-08-0145897197510.1002/cac2.70035Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patientsEdmund Chiong0Ziteng Wang1Eleanor Jing Yi Cheong2Yi Chen Yao3Sin Mun Tham4Revathi Periaswami5Poh Choo Toh6Ziting Wang7Qing Hui Wu8Woon Chau Tsang9Arshvin Kesavan10Alvin Seng Cheong Wong11Patrick Thomas Wong12Felicia Lim13Shuaibing Liu14Eric Chun Yong Chan15Department of Surgery Yong Loo Lin School of Medicine, National University of Singapore Singapore SingaporeDepartment of Pharmacy and Pharmaceutical Sciences National University of Singapore Singapore SingaporeDepartment of Pharmacy and Pharmaceutical Sciences National University of Singapore Singapore SingaporeDepartment of Pharmacy and Pharmaceutical Sciences National University of Singapore Singapore SingaporeDepartment of Surgery Yong Loo Lin School of Medicine, National University of Singapore Singapore SingaporeDepartment of Surgery Yong Loo Lin School of Medicine, National University of Singapore Singapore SingaporeDepartment of Urology National University Hospital, National University Health System Singapore SingaporeDepartment of Urology National University Hospital, National University Health System Singapore SingaporeDepartment of Urology National University Hospital, National University Health System Singapore SingaporeDepartment of Urology National University Hospital, National University Health System Singapore SingaporeDepartment of Urology National University Hospital, National University Health System Singapore SingaporeDepartment of Haematology‐Oncology National University Cancer Institute Singapore SingaporeDepartment of Pharmacy National University Hospital, National University Health System Singapore SingaporeDepartment of Pharmacy National University Hospital, National University Health System Singapore SingaporeDepartment of Pharmacy The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan P. R. ChinaDepartment of Pharmacy and Pharmaceutical Sciences National University of Singapore Singapore Singaporehttps://doi.org/10.1002/cac2.70035 |
| spellingShingle | Edmund Chiong Ziteng Wang Eleanor Jing Yi Cheong Yi Chen Yao Sin Mun Tham Revathi Periaswami Poh Choo Toh Ziting Wang Qing Hui Wu Woon Chau Tsang Arshvin Kesavan Alvin Seng Cheong Wong Patrick Thomas Wong Felicia Lim Shuaibing Liu Eric Chun Yong Chan Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients Cancer Communications |
| title | Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients |
| title_full | Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients |
| title_fullStr | Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients |
| title_full_unstemmed | Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients |
| title_short | Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients |
| title_sort | evaluation of exposure response safety relationship of model informed low dose 500 mg abiraterone acetate in prostate cancer patients |
| url | https://doi.org/10.1002/cac2.70035 |
| work_keys_str_mv | AT edmundchiong evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT zitengwang evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT eleanorjingyicheong evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT yichenyao evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT sinmuntham evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT revathiperiaswami evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT pohchootoh evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT zitingwang evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT qinghuiwu evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT woonchautsang evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT arshvinkesavan evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT alvinsengcheongwong evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT patrickthomaswong evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT felicialim evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT shuaibingliu evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients AT ericchunyongchan evaluationofexposureresponsesafetyrelationshipofmodelinformedlowdose500mgabirateroneacetateinprostatecancerpatients |